AGILYSYS INC Earnings Per Share Disclosure
12. Earnings per Share
The following data shows the amounts used in computing earnings per share and the effect on earnings and the weighted average number of shares of dilutive potential common shares.
|
Year Ended March 31, |
|
|||||||||
(In thousands, except per share data) |
2025 |
|
|
2024 |
|
|
2023 |
|
|||
Numerator: |
|
|
|
|
|
|
|
|
|||
Net income |
$ |
23,225 |
|
|
$ |
86,195 |
|
|
$ |
14,582 |
|
Series A convertible preferred stock dividends |
|
— |
|
|
|
(1,204 |
) |
|
|
(1,836 |
) |
Net income attributable to common shareholders |
$ |
23,225 |
|
|
$ |
84,991 |
|
|
$ |
12,746 |
|
|
|
|
|
|
|
|
|
|
|||
Denominator: |
|
|
|
|
|
|
|
|
|||
Weighted average shares outstanding - basic |
|
27,518 |
|
|
|
25,668 |
|
|
|
24,694 |
|
Dilutive SSARs |
|
472 |
|
|
|
929 |
|
|
|
1,059 |
|
Dilutive unvested restricted stock units |
|
40 |
|
|
|
10 |
|
|
|
— |
|
Dilutive unvested restricted shares |
|
227 |
|
|
|
234 |
|
|
|
176 |
|
Weighted average shares outstanding - diluted |
|
28,257 |
|
|
|
26,842 |
|
|
|
25,929 |
|
|
|
|
|
|
|
|
|
|
|||
Income per share - basic: |
$ |
0.84 |
|
|
$ |
3.31 |
|
|
$ |
0.52 |
|
Income per share - diluted: |
$ |
0.82 |
|
|
$ |
3.17 |
|
|
$ |
0.49 |
|
|
|
|
|
|
|
|
|
|
|||
Anti-dilutive SSARs, restricted shares, restricted stock units, performance shares, and preferred shares |
|
132 |
|
|
|
175 |
|
|
|
1,741 |
|
Basic income per share is computed as net income available to common shareholders divided by the weighted average basic shares outstanding. The outstanding shares used to calculate the weighted average basic shares excludes 229,710, 436,177 and 407,324 of restricted shares at March 31, 2025, 2024 and 2023, respectively, as these shares were issued but
were not vested and, therefore, not considered outstanding for purposes of computing basic earnings per share at the balance sheet dates.
Diluted income per share includes the effect of all potentially dilutive securities on earnings per share. We have stock-settled appreciation rights (SSARs), unvested restricted shares, restricted stock units, employee stock purchase plan (ESPP) shares, and performance shares, that are potentially dilutive securities. When a loss is reported, the denominator of diluted earnings per share cannot be adjusted for the dilutive impact of share-based compensation awards because doing so would be anti-dilutive.
Historical Timeline
| Fiscal Year | Filed | |
|---|---|---|
| 2025 | May 23, 2025 | Showing above |
| 2024 | May 22, 2024 | |
| 2023 | May 19, 2023 | |
| 2022 | May 23, 2022 | |
| 2021 | May 21, 2021 | |
| 2020 | May 22, 2020 | |
| 2019 | May 24, 2019 | |
About Earnings Per Share Disclosures
The earnings per share disclosure breaks down the calculation from net income to both basic and diluted EPS, revealing the full impact of a company's capital structure on per-share economics. The reconciliation between basic and diluted share counts exposes how many stock options, RSUs, convertible securities, and warrants are potentially dilutive to existing shareholders.
Key signals: a widening gap between basic and diluted shares indicates growing dilution from equity compensation or convertible instruments. Anti-dilutive securities excluded from the diluted calculation deserve attention — they represent latent dilution that will materialize if the stock price rises. Watch for the effect of share buybacks on per-share metrics: EPS growth driven primarily by repurchases rather than income growth signals weakening fundamentals. Compare year-over-year changes in the diluted share count against equity compensation expense to assess whether management is effectively managing dilution.